Epoetin theta
Biopoin, Eporatio (epoetin theta) is a protein pharmaceutical. Epoetin theta was first approved as Biopoin on 2009-10-23. It has been approved in Europe to treat anemia, chronic kidney failure, and neoplasms.
| Trade Name | Biopoin, Eporatio |
|---|---|
| Common Name | Epoetin theta |
| Indication | anemia, chronic kidney failure, neoplasms |
| Drug Class | Erythropoietins |
